1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Assess the Efficiency of Trastuzumab Deruxtecan in Russian Breast Cancer PatientsHER2-positive Breast Cancer; Trastuzumab DeruxtecanRecruitingNot applicable2025-12-15NCT07281001